Novavax, an American vaccine development company, has developed a vaccine against the novel coronavirus (COVID-19) that successfully induces immunity and protection against the virus in macaques. The vaccine is developed from the spike protein that the virus uses to bind human receptor angiotensin-converting enzyme 2 (ACE2) and gain access to host cells. The virus uses the viral membr... https://www.coherentmarketinsights.com/news/new-coronavirus-vaccine-effective-in-macaques-148